Precipio Inc
NASDAQ:PRPO
| Market Cap (Intraday) | 51.21M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $2.53 |
| 50-Day MA | $2.92 |
| 200-Day MA | $3.01 |
Precipio Inc Stock, NASDAQ:PRPO
4 Science Park, 3rd floor, New Haven, Connecticut 06511
United States of America
Phone: +1.203.787.7888
Number of Employees: 57
Description
Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. Its products include ICP, HemeScreen, and IV-Cell, and services include primary diagnostic, SmartPath, SmartGen, HemeScreen Panel, and ICE COLD-PCR. The company was founded on March 6, 1997 and is headquartered in New Haven, CT.